全文获取类型
收费全文 | 221524篇 |
免费 | 20442篇 |
国内免费 | 15545篇 |
专业分类
耳鼻咽喉 | 1921篇 |
儿科学 | 2199篇 |
妇产科学 | 2994篇 |
基础医学 | 26694篇 |
口腔科学 | 3702篇 |
临床医学 | 30999篇 |
内科学 | 33136篇 |
皮肤病学 | 2235篇 |
神经病学 | 12436篇 |
特种医学 | 8292篇 |
外国民族医学 | 138篇 |
外科学 | 21892篇 |
综合类 | 35772篇 |
现状与发展 | 55篇 |
一般理论 | 19篇 |
预防医学 | 13266篇 |
眼科学 | 6702篇 |
药学 | 22989篇 |
200篇 | |
中国医学 | 12480篇 |
肿瘤学 | 19390篇 |
出版年
2024年 | 710篇 |
2023年 | 3588篇 |
2022年 | 9276篇 |
2021年 | 11675篇 |
2020年 | 8677篇 |
2019年 | 7601篇 |
2018年 | 8075篇 |
2017年 | 7144篇 |
2016年 | 6702篇 |
2015年 | 10328篇 |
2014年 | 12674篇 |
2013年 | 10780篇 |
2012年 | 16106篇 |
2011年 | 18066篇 |
2010年 | 10602篇 |
2009年 | 8241篇 |
2008年 | 11185篇 |
2007年 | 11165篇 |
2006年 | 11295篇 |
2005年 | 11388篇 |
2004年 | 7043篇 |
2003年 | 6668篇 |
2002年 | 5541篇 |
2001年 | 4998篇 |
2000年 | 5394篇 |
1999年 | 5733篇 |
1998年 | 3543篇 |
1997年 | 3520篇 |
1996年 | 2830篇 |
1995年 | 2621篇 |
1994年 | 2149篇 |
1993年 | 1387篇 |
1992年 | 1905篇 |
1991年 | 1603篇 |
1990年 | 1297篇 |
1989年 | 1096篇 |
1988年 | 1019篇 |
1987年 | 892篇 |
1986年 | 728篇 |
1985年 | 526篇 |
1984年 | 338篇 |
1983年 | 242篇 |
1982年 | 149篇 |
1981年 | 145篇 |
1980年 | 112篇 |
1979年 | 142篇 |
1978年 | 49篇 |
1977年 | 53篇 |
1975年 | 57篇 |
1974年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
62.
目的 初步建立阴道粘膜上皮细胞体外培养方法,为阴道粘膜上皮研究提供实验模型.方法 取雌性新西兰大白兔阴道粘膜组织小块,胶原酶Ⅳ和胰蛋白酶联合消化分离法收集上皮细胞,接种于角朊细胞无血清培养液中静置培养、传代.动态观察细胞生长增殖情况,扫描和透射电镜观察超微结构,流式细胞仪测定细胞增殖周期,并进行免疫组织化学鉴定.结果 体外培养的阴道粘膜上皮细胞为二倍体细胞,增殖状态良好,细胞间可见桥粒连接,免疫组化角蛋白染色阳性.细胞的超微结构和免疫组化染色均具有上皮细胞特征.结论 在本实验条件下,体外培养的阴道粘膜上皮细胞具有较好的增殖能力,可作为阴道粘膜上皮研究的理想实验模型. 相似文献
63.
64.
目的:建立乳腺非典型增生病动物模型,探讨非典型增生与血管生成的关系。方法:采用灌服二甲基苯蒽+颈部枷具方法复制大鼠肝郁血瘀型乳腺非典型增生动物模型,并给予中药乳复汤治疗。常规染色观察大鼠乳腺组织病理组织形态.免疫组化方法检测MVD、VEGF和bFGF的表达。结果:病证模型组乳腺非典型增生率90%.较单纯造模组高.P=0.0415;中药乳复汤治疗组非典型增生率较病证模型组低.P=0.0459;随着一般增生到非典型增生程度加重,MVD计数增多,VEGF、bFGF的表达升高,P〈0.05。结论:病证结合造模更适合中医动物实验要求,中药乳复汤具有抑制血管生成作用。 相似文献
65.
The authors reviewed the radiographic manifestations of 17 cases of parosteal osteosarcoma, with pathologic correlation in 15. There were two types of parosteal osteosarcoma radiologically. The majority of cases were type I with uniformly dense masses which had regular borders. They often adhered to the cortex and showed no evidence of soft-tissue invasion which correlated with low-grade pathologic malignancy and a relatively benign clinical course. Type II involved the bone, soft-tissue and the medullary cavity. These lesions were poorly differentiated and frequently accompanied by metastatic lesions.
相似文献
66.
67.
Fengxiu Ouyang Binyan Wang Lester M. Arguelles Xiping Xu Jianhua Yang Zhiping Li Liuliu Wang Xue Liu Genfu Tang Houxun Xing Craig Langman Xiaobin Wang 《Archives of osteoporosis》2007,2(1-2):29-43
Summary We prospectively examined bone growth patterns in 894 children aged 6–17 years at the baseline visit, with a 6-year follow-up.
Results show bone “tracking” over a six-year interval and sexual dimorphism of bone attained levels and timing of peak bone
growth. Our findings underscore childhood and adolescence as critical periods for building bone and developing gender differences.
Introduction Bone growth patterns were prospectively examined in 894 Chinese children (496 males), aged 6–17 yrs, from a population-based
twin cohort. Whole-body bone area (BA), bone mineral content (BMC), and bone mineral density (BMD) were measured by DEXA at
baseline and a 6-yr follow-up.
Methods Graphic smoothing plots and generalized estimating equations were used to model bone attained levels, growth, and “tracking”.
Results Attained levels of BMC and BA increased curvilinearly with age. Male attained levels were higher than females after age ∼15 yr,
but BMD was lower between 13–17 yrs (Tanner stage I to IV). In both genders, peak BMC and BMD growth lagged ∼2 yrs behind
peak BA growth, which lagged 2 yrs behind peak height growth. Peak bone growth occurred 1–3 yrs later in males. Over the 6-yr
follow-up, all bone measurements “tracked”, but “shifting” across ranks also occurred, and baseline tertile ranking influenced
bone growth. Females with early menarche had higher attained levels than females with late menarche at age 12–13 yrs.
Conclusion Our findings confirm and expand previous studies on peak bone growth conducted in Caucasian cohorts, particularly sexually
dimorphic and maturational effects. The significant “tracking” of bone measurements in this 6-yr follow-up study underscores
the importance that osteoporosis prevention should begin in childhood and adolescence.
Fengxiu Ouyang and Binyan Wang contributed equally to this article.
Source(s) of support: This study is supported in part by grant R01 HD049059, R01 HL0864619 and R01 AR045651 from the National
Institute of Health and by the Food Allergy Project. 相似文献
68.
69.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
70.
一般护理记录单是住院病历的一部分,根据卫生部、中医药管理局公布的《病历书写基本规范》(试行)的规定,一般护理记录的定义是:护士根据医嘱和病情对一般病人住院期间护理过程的客观记录,内容包括病人姓名、记录日期和时间、病情观察、护理措施和效果、护士签名。现将护士在一般护理书写中存在认识上的理解偏差分析如下。 相似文献